/ prospectus / notice and the report submitted by the monitoring agency monitoring the utilisation of proceeds of a public or rights issue, and making appropriate recommendations to the board to take up steps in this matter;

6. Review and monitor effectiveness of the audit process.

7. Review and monitor the auditor's independence, performance and qualifications, including an evaluation of the lead audit partner; and to assure the regular rotation of the lead audit partner and consider regular rotation of the accounting firm serving as the independent auditors.

8. Review with the Management, performance of Statutory and Internal auditors and adequacy of the internal control systems.

9. Evaluate Internal Financial Controls and Risk Management systems and call for comments by the auditors about internal control systems/scope of audit, including the observations of the auditors and review of financial statement before their submission to the Board and discuss any related issues with the Internal and statutory auditors and the Management of the Company.

10. Review of the adequacy of internal audit function, if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage and frequency of internal audit;

11. Discussion with internal auditors of any significant findings and follow up thereon and review the findings of any investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board.

12. Review material issues raised in any inquiry or investigation by governmental or professional authorities, regarding any independent audit performed by the independent auditor, during their tenure with the Company, and any steps taken to deal with any such issues.

13. Review proposals for fund raising, mergers and acquisitions, making investments or sale of investment/ assets.

14. Consider and comment on rationale, cost-benefits and impact of schemes involving merger, demerger, amalgamation etc., on the listed entity and its shareholders.

15. Review with the Management, and independent auditors, any prospectus or such other document including financial statements contained therein, proposed to be issued by the Company for the purpose of raising capital.

16. Monitoring of end use of funds raised through public offers and related matters.

17. Monitoring and review of the utilization of loans and/ or advances from/investment in the subsidiary companies exceeding rupees 100 crore or 10% of the asset size of the subsidiary/associate companies, whichever is lower; including existing loans / advances / investments existing as on the date of coming into force of this provision.

18. Review the reasons for substantial defaults in payment to the depositors, debenture holders, shareholders (in case of non-payment of declared dividends) and creditors, if any.

19. Periodically review the treasury policy of the Company.

20. Review the functioning of the Vigil / Whistle Blower Mechanism.

21. Review of compliance with the Code of Business Conduct & Ethics, Prevention of Sexual Harassment at Workplace Policy, Conflict of Interest Policy, Anti-Trust Policy and Anti-Corruption and Bribery Policy.

22. Note report of compliance officer as per SEBI (Prohibition of Insider Trading) Regulations, 2015;

23. Review of secretarial audit report, cost audit report and other audit report as required under the applicable laws.

24. Review, in conjunction with legal counsel, any legal matters that could have a significant impact on the Company's financial statements/position.

25. Review the following:

a. Management discussion and analysis of financial condition and results of operation.

b. Statement of significant related party transactions (as defined by the audit committee), submitted by management; Provided that only those members of the Audit Committee, who are independent directors, shall approve related party transactions

c. Management letters / letters of internal control weaknesses issued by the statutory auditors including Internal audit reports relating to internal control weaknesses.

d. Statement of deviations, if any in the use of proceeds as against the objects for which the funds were raised.

e. Review the statement of deviations:

i. quarterly statement of deviation(s) including report of monitoring agency, if applicable, submitted to stock exchange(s) in terms of Regulation 32(1).

ii. annual statement of funds utilized for purposes other than those stated in the offer document/prospectus/notice in terms of Regulation 32(7).

f. Review, at least on a quarterly basis, the details of related party transactions entered into by the Company pursuant to each of the omnibus approvals given.

## B. Approval Role

26. Approval of other non-audit services rendered by the statutory auditors including finalization of fees for such other services;

27. Approval or any subsequent modification of transactions of the Company with the related parties or recommendation of the same to the Board.

28. Approval of appointment of the Chief Financial Officer and Chief Internal Auditor after assessing the qualifications,